Literature DB >> 19550231

Selection of outcome measures for patients with hip fracture.

Dianne M Bryant1, David W Sanders, Chad P Coles, Brad A Petrisor, Kyle J Jeray, George Yves Laflamme.   

Abstract

In designing a study protocol relating to hip fracture treatment and outcomes, it is important to select appropriate outcome instruments. Before beginning the process of instrument selection, investigators must gain a comprehensive understanding of the condition of interest and have a thorough knowledge of the expected benefits and harms of the proposed intervention. Adequate evidence of an intervention's effectiveness includes indication of impact on the patient's health. We provide a brief discussion about different ways that health and health measurement have been defined, including the International Classification of Function, Disability and Health (ICF), health-related quality of life (HRQOL), and cost-to-benefit analyses. We outline important properties (reliability, validity, sensitivity to change, and responsiveness) that a measurement instrument must demonstrate before being considered an acceptable means to measure outcome. Potential outcome measures relevant to patients with hip fracture are summarized, and important points to consider in the selection of outcome measures for a hypothetical research question in a hip fracture population are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19550231     DOI: 10.1097/BOT.0b013e318162aaf9

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  12 in total

Review 1.  Patient-reported outcome measures in older people with hip fracture: a systematic review of quality and acceptability.

Authors:  K L Haywood; J Brett; E Tutton; S Staniszewska
Journal:  Qual Life Res       Date:  2016-10-20       Impact factor: 4.147

2.  [Outcome assessment in geriatric trauma].

Authors:  K E Dreinhöfer; S R Schwarzkopf
Journal:  Unfallchirurg       Date:  2010-06       Impact factor: 1.000

3.  Use of a Trochanteric Fixation Nail-Advanced (TFNA) with cement augmentation for treatment of trochanteric fractures in patients greater than sixty five years of age.

Authors:  Marie Fernandez; Yoann David; Frédéric Dubrana; Rémi Di Francia
Journal:  Int Orthop       Date:  2022-01-16       Impact factor: 3.075

Review 4.  [Proximal femoral fractures in the elderly].

Authors:  Carl Neuerburg; M Gosch; W Böcker; M Blauth; C Kammerlander
Journal:  Z Gerontol Geriatr       Date:  2015-10       Impact factor: 1.281

5.  An interdisciplinary intervention for older Taiwanese patients after surgery for hip fracture improves health-related quality of life.

Authors:  Yea-Ing L Shyu; Jersey Liang; Chi-Chuan Wu; Huey-Shinn Cheng; Min-Chi Chen
Journal:  BMC Musculoskelet Disord       Date:  2010-09-29       Impact factor: 2.362

Review 6.  Design and execution of clinical trials in orthopaedic surgery.

Authors:  R Mundi; H Chaudhry; S Mundi; K Godin; M Bhandari
Journal:  Bone Joint Res       Date:  2014-05       Impact factor: 5.853

7.  Routine functional assessment for hip fracture patients.

Authors:  Tonny J Pedersen; Jens M Lauritsen
Journal:  Acta Orthop       Date:  2016-06-22       Impact factor: 3.717

8.  Handgrip strength is an independent predictor of functional outcome in hip-fracture women: a prospective study with 6-month follow-up.

Authors:  Marco Di Monaco; Carlotta Castiglioni; Elena De Toma; Luisa Gardin; Silvia Giordano; Rosa Tappero
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

Review 9.  Scoping review of potential quality indicators for hip fracture patient care.

Authors:  Kristen B Pitzul; Sarah E P Munce; Laure Perrier; Lauren Beaupre; Suzanne N Morin; Rhona McGlasson; Susan B Jaglal
Journal:  BMJ Open       Date:  2017-03-21       Impact factor: 2.692

10.  Effects of interventions on trajectories of health-related quality of life among older patients with hip fracture: a prospective randomized controlled trial.

Authors:  Ming-Yueh Tseng; Jersey Liang; Yea-Ing L Shyu; Chi-Chuan Wu; Huey-Shinn Cheng; Ching-Yen Chen; Shu-Fang Yang
Journal:  BMC Musculoskelet Disord       Date:  2016-03-03       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.